Kelonia Therapeutics

Boston, United States

Kelonia Therapeutics develops genetic medicines focused on in vivo gene delivery and cell therapy for cancer and other diseases.

Apr 2022

Series A

Biotechnology Genetics Health Care Medical Therapeutics

Top Investors

VenrockAlta PartnersHorizons Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kelonia Therapeutics

Who are Kelonia Therapeutics's investors?

Kelonia Therapeutics's investors include Venrock, Alta Partners, Horizons Ventures.

Where is Kelonia Therapeutics headquartered?

Kelonia Therapeutics is headquartered in Boston, United States.

What does Kelonia Therapeutics do?

Kelonia Therapeutics develops genetic medicines focused on in vivo gene delivery and cell therapy for cancer and other diseases.

What stage is Kelonia Therapeutics at?

Kelonia Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 28, 2022.

MLA

"Kelonia Therapeutics — Funding & Investors." VCBacked, April 28, 2022, https://www.vcbacked.co/company/kelonia-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2022). Kelonia Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/kelonia-therapeutics

Wikipedia (cite web)

{{cite web |title=Kelonia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kelonia-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 28, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.